Clinical Trial Update: Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder [NA]

View source ↗

Summary

A clinical trial evaluating imaging of serotonin 5-HT1A receptors in patients with major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Major Depression, Unipolar Depression | NA | Status: WITHDRAWN